NCT02836457View on ClinicalTrials.gov

ELIQUIS (APIXABAN) Regulatory Post-Marketing Surveillance In Clinical Practice for Venous Thromboembolism (VTE) Treatment and Prevention Of Recurrent VTE

CompletedOBSERVATIONAL
Enrollment

1,134

Participants

Timeline

Start Date

July 1, 2016

Primary Completion Date

July 31, 2018

Study Completion Date

July 31, 2018

Conditions
Venous Thromboembolism
Trial Locations (1)

162-0822

Local Institution, Shinjuku-ku

Sponsors
All Listed Sponsors
lead

Bristol-Myers Squibb

INDUSTRY